Literature DB >> 22853779

Patients with therapy-related myelodysplastic syndromes and acute myeloid leukemia share genetic features but can be separated by blast counts and cytogenetic risk profiles into prognostically relevant subgroups.

Ulrike Bacher, Claudia Haferlach, Tamara Alpermann, Susanne Schnittger, Wolfgang Kern, Torsten Haferlach.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22853779     DOI： 10.3109/10428194.2012.717275

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  7 in total

1.  Application of the international prognostic scoring system-revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia.

Authors:  C Y Ok; R P Hasserjian; P S Fox; F Stingo; Z Zuo; K H Young; K Patel; L J Medeiros; G Garcia-Manero; S A Wang
Journal:  Leukemia       Date:  2013-06-21       Impact factor: 11.528

Review 2.  A focused review of hematopoietic neoplasms occurring in the therapy-related setting.

Authors:  Liping Zhang; Sa A Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome.

Authors:  Arjen H G Cleven; Valentina Nardi; Chi Young Ok; Maitrayee Goswami; Paola Dal Cin; Zongli Zheng; A John Iafrate; Myrurgia A Abdul Hamid; Sa A Wang; Robert P Hasserjian
Journal:  Mod Pathol       Date:  2014-11-21       Impact factor: 7.842

4.  Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.

Authors:  Chi Young Ok; Keyur P Patel; Guillermo Garcia-Manero; Mark J Routbort; Bin Fu; Guilin Tang; Maitrayee Goswami; Rajesh Singh; Rashmi Kanagal-Shamanna; Sherry A Pierce; Ken H Young; Hagop M Kantarjian; L Jeffrey Medeiros; Rajyalakshmi Luthra; Sa A Wang
Journal:  Leuk Res       Date:  2014-12-20       Impact factor: 3.156

Review 5.  Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Acute Leukemia.

Authors:  Ram Vasudevan Nampoothiri; Auro Viswabandya
Journal:  Indian J Hematol Blood Transfus       Date:  2020-08-12       Impact factor: 0.915

6.  The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution.

Authors:  Hamish S Scott; Christopher N Hahn; Devendra K Hiwase; Deepak Singhal; Li Yan A Wee; Monika M Kutyna; Rakchha Chhetri; Joel Geoghegan; Andreas W Schreiber; Jinghua Feng; Paul P-S Wang; Milena Babic; Wendy T Parker; Smita Hiwase; Suzanne Edwards; Sarah Moore; Susan Branford; Teodora Kuzmanovic; Nimit Singhal; Raghu Gowda; Anna L Brown; Peer Arts; Luen B To; Peter G Bardy; Ian D Lewis; Richard J D'Andrea; Jaroslaw P Maciejewski
Journal:  Leukemia       Date:  2019-05-14       Impact factor: 11.528

7.  Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.

Authors:  A Kuendgen; M Nomdedeu; H Tuechler; G Garcia-Manero; R S Komrokji; M A Sekeres; M G Della Porta; M Cazzola; A E DeZern; G J Roboz; D P Steensma; A A Van de Loosdrecht; R F Schlenk; J Grau; X Calvo; S Blum; A Pereira; P Valent; D Costa; A Giagounidis; B Xicoy; H Döhner; U Platzbecker; C Pedro; M Lübbert; I Oiartzabal; M Díez-Campelo; M T Cedena; S Machherndl-Spandl; M López-Pavía; C D Baldus; M Martinez-de-Sola; R Stauder; B Merchan; A List; C Ganster; T Schroeder; M T Voso; M Pfeilstöcker; H Sill; B Hildebrandt; J Esteve; B Nomdedeu; F Cobo; R Haas; F Sole; U Germing; P L Greenberg; D Haase; G Sanz
Journal:  Leukemia       Date:  2020-06-29       Impact factor: 11.528
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.